MIERZWA, Monika, Adrianna CYTRYNIAK, Pawel KRYSINSKI and Renata BILEWICZ. Lipidic Liquid Crystalline Cubic Phases and Magnetocubosomes as Methotrexate Carriers. Nanomaterials. BASEL: MDPI, 2019, vol. 9, No 4, p. 1-17. ISSN 2079-4991. Available from: https://dx.doi.org/10.3390/nano9040636.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Lipidic Liquid Crystalline Cubic Phases and Magnetocubosomes as Methotrexate Carriers
Authors MIERZWA, Monika, Adrianna CYTRYNIAK, Pawel KRYSINSKI and Renata BILEWICZ.
Edition Nanomaterials, BASEL, MDPI, 2019, 2079-4991.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 21000 2.10 Nano-technology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.324
Doi http://dx.doi.org/10.3390/nano9040636
UT WoS 000467768800152
Keywords in English methotrexate; cubic phase; magnetocubosomes; monoolein; liquid crystalline phase; drug delivery system; alternating magnetic field
Tags CF CRYO
Tags International impact, Reviewed
Changed by Changed by: Mgr. Eva Dubská, učo 77638. Changed: 11/6/2024 09:28.
Abstract
The release profiles of methotrexate, an anticancer drug, from the monoolein liquid crystalline cubic phases were studied. The cubic phases were used either in the form of a lipidic film deposited onto a glassy carbon electrode surface or in the dispersed form of magnetocubosomes, which are considered a prospective hybrid drug delivery system. Commonly, cubosomes or liposomes are employed, but not in the case of toxic methotrexate, known to block the receptors responsible for folate transport into the cells. The release profiles of the drug from the lipidic films were monitored electrochemically and described using the Higuchi model. They were also modified via changes in temperature; the release was faster, although it deviated from the model when the temperature was increased. Cubic phase nanoparticles (magnetocubosomes) containing hydrophobic magnetic nanoparticles placed in an alternating magnetic field of low frequency and amplitude, stimulated drug release from the suspension, which was monitored spectroscopically. These new biocompatible hybrid nanomaterials in the dispersed form allow to control the release of the drug at the appropriate sites, can be easily separated or relocated under external magnetic field and await further investigations of their in vitro cytotoxicity and in vivo biodistribution.
Links
90127, large research infrastructuresName: CIISB II
PrintDisplayed: 24/7/2024 04:20